Nutra Pharma (NPHC) Short Interest Ratio & Short Volume

Short interest is the volume of Nutra Pharma shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 4,900 shares of NPHC short. Learn More on Nutra Pharma's current short interest.

Nutra Pharma saw a drop in short interest in June. As of June 30th, there was short interest totaling 4,900 shares, a drop of 2.0% from the previous total of 5,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nutra Pharma: Avenue Therapeutics, Inc. (2.41%), iBio, Inc. (6.09%), PainReform Ltd. (7.61%), Azitra, Inc. (30.00%), Ayr Wellness Inc. (0.71%), Virax Biolabs Group Limited (9.00%), Universe Pharmaceuticals INC (9.25%), Salarius Pharmaceuticals, Inc. (24.46%), Can-Fite BioPharma Ltd. (5.06%), Galmed Pharmaceuticals Ltd. (3.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Corporation ($3.35 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Corporation ($2.80 billion), Coinbase Global, Inc. ($2.58 billion), Royal Caribbean Cruises Ltd. ($2.17 billion), Moderna, Inc. ($2.13 billion), T. Rowe Price Group, Inc. ($2.11 billion), Palantir Technologies Inc. ($2.03 billion), Extra Space Storage Inc ($1.81 billion), and Verisk Analytics, Inc. ($1.63 billion). View all of the most shorted stocks.

Short selling NPHC is an investing strategy that aims to generate trading profit from Nutra Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nutra Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NPHC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NPHC, twice per month. The most recent reporting period available is June, 30 2023.